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ABSTRACT

Bueno, Amy N. M.S., Purdue University, May 2015. An Active Site Mutant of a Zinc
Metallo‐Deubiquitinase Suggests the Importance of Loop Dynamics to Catalysis. Major
Professor: Chittaranjan Das.

AMSH is a conserved zinc metalloprotease that functions with endosomal sorting
complexes required for transport (ESCRT) machinery in order to down regulate and
degrade cell‐surface receptors. It has high specificity toward Lys63‐linked polyubiquitin
chains, a signal used for receptor down regulation by the ESCRT machinery. It has
previously been found that Sst2, an AMSH orthologue from fission yeast, contains a
flexible “loop”, referred to herein as the active‐site flap, near the proximal ubiquitin
binding site, composed of Leu402 and Phe403. Mobility of the side chains of these
residues contributes to the opening and closing conformation of the catalytic cleft which
may play important role in catalysis. The dynamics of the active‐site flap may also
contribute to linkage specificity. To gain insight into the role played by the active‐site
flap in catalysis, point mutants of the conserved Phe are generated. Reported herein
are studies of a Trp mutant (Phe403Trp) of Sst2 using X‐ray crystallography, enzyme
kinetics, isothermal calorimetry (ITC), and circular dichroism (CD) which indicate the
importance of dynamics of the flap in catalysis and substrate selectivity of the enzyme.

xiii
Kinetic measurement of the tryptophan mutant showed a decreased value in kcat
by about 10‐fold from that of wild type, while the KM was relatively unchanged. This
indicates that while catalytic activity of the mutant was significantly impaired, substrate
binding affinity was not affected. To prove that this decrease in catalytic activity was
not due to a structural change, circular dichroism and thermal denaturation was
analyzed. This data showed that the secondary structures of the mutant protein was
almost identical to that of wild type, ruling out a structural change in the mutant
accounting for the decrease in catalytic activity. This was further corroborated by the X‐
ray structure of the mutant which showed almost no appreciable structural alteration
resulting from the mutation.
ITC titration data was obtained for the tryptophan mutant binding to
monoubiquitin and K63‐linked diubiquitin, both showing that product binding is
unchanged. This is supported by the x‐ray structure of the mutant bound to ubiquitin
which showed nearly identical mode of binding compared to the wild‐type enzyme.
Finally, cleavage of various chain types of diubiquitin (K11, K48, and K63) by the mutant
was measured. Results from this study indicate that the tryptophan mutant may allow
cleavage of other chain types due to an increased flexibility in the flap.
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CHAPTEER 1.

1.1
1

INTR
RODUCTION

Ubiquitinnation

Ubiquittin (Ub) is a small
s
8.5 kD
Da protein thhat spans 766 amino acids in length aand is
ound in eukkaryotic orgganisms.1 It can be covvalently ligaated to oth
her proteinss and
fo
primarily functions as siggnaling for degradation.
d
. In addition
n to degradaation, ubiquiitin is
in
nvolved in other regulatory bioch
hemical proocesses, inccluding sign
nal transducction,
re
egulation of
o transcrip
ption, prote
ein‐protein interaction
ns, endocyttosis, cell cycle
progression, and activity//localization
n of substratees (Figure 1..1).2,3,4

Figure 1.1 Fattes of Ubiquiitinated protteins5

2
Ubiqu
uitination is a post translational moodification in which ubiquitin is ab
ble to
fo
orm an isopeptide bond
d with a targget protein, linking a lysine side ch
hain of the target
to
o the terminal glycine (Gly76) of ubiquitin.6 TThis requirees the use of three disstinct
enzymes: ub
biquitin activvating enzym
mes (E1s), u biquitin con
njugating enzymes (E2s)), and
ubiquitin ligaases (E3s). In
n the first ATP‐depende
A
ent step, an
n E1 enzymee binds ubiq
quitin
n adenylated intermediate (Figure 1.2). Ubiquitin is transfeerred
and ATP and catalyzes an
o an active cysteine
c
residue while AMP
A
is releaased, formin
ng a thioesteer bond betw
ween
to
th
he C‐terminaal carboxylatte group of ubiquitin annd a cystine ssulfhydryl grroup of E1. In the
se
econd step
p, E2 bind
ds to the
e activatedd ubiquitin and E1 enzyme in a
trrans(thio)estterification reaction to catalyze ubbiquitin’s traansfer from E1 to the aactive
siite cysteine of E2.7 In the
t final ste
ep, an isope ptide bond is formed b
between a lysine
re
esidue of the
e protein an
nd the C‐term
minal glycinee of ubiquitiin. E3 is ablee to interactt with
E2s and recrruits the tarrget substratte as well, ultimately ttransferring ubiquitin to
o the
protein of intterest.8

Figure
e 1.2 The pro
ocess of ubiq
quitination, mediated byy E1, E2, and
d E3 ligases

3
Ubiqu
uitin is highlyy conserved
d among eukkaryotes; ho
owever, it sh
hows diverssity in
th
he way in which
w
it is ab
ble to attach
h to substrattes.9 Protein
ns to be deggraded can eeither
be monoubiq
quinated or polyubiquin
nated by hoomogenous chains of u
ubiquitin only, or
heterogeneous chains of
o both ubiq
quitin and ubiquitin like moleculees. Polyubiq
quitin
ch
hains are named by th
he lysine in which chaiin extension
n attachmen
nt occurs, w
which
in
ncludes lysin
ne 6, 11, 27, 29, 33, 48
8, or 63 (Fig ure 1.3).10 Interestinglyy, these diffeerent
ch
hains are ab
ble to signal different fates for the pproteins in w
which they aare attached
d. For
exxample, K63
3 chains sign
nal for DNA repair and eendosomal‐lysosomal so
orting, whilee K48
ch
hains signal or proteasomal degradaation.11

Figure 1.3 The different types
t
of ubiq
quitin chainss based on linkage and tthe function each
ch
hain type serrves12

4
1.2

De
eubiquitinatiing Enzymess

Deubiquitinating enzymes (DU
UBs) are a cllass of enzymes that haave the ability to
clleave ubiquitin chains frrom proteinss to which thhey are covaalently bonded, reversin
ng the
process of ub
biquitination
n.13 When th
he ubiquitinn moieties aare removed
d, the fate o
of the
protein is esssentially revversed. The functions o f DUBs can be sorted iinto four gro
oups:
p
ming, recycliing ubiquitin
n from a prrotein
processing off ubiquitin precursors,
chain trimm
egradation, and
a disassem
mbly of free ubiquitin ch
hains (Figuree 1.4).14
taagged for de

Figure 1.4 General
G
funcctions of DUB
Bs14

There
e are about 100 known DUBs in thee human genome, whicch can be brroken
down into 5 major
m
classe
es based on their catalyttic domain sstructure, including ubiq
quitin
sp
pecific prote
eases (USP), ovarian tum
mor associatted proteinss (OTU), ubiquitin c‐term
minal
hydrolases (U
UCH), Machado‐Josephiin Domain pproteins (MJD), and JAB1/MNP/MO
OV34
eins (JAMM) (Figure 1.5)).15
domain prote

5

Figure 1..5 Classificattion of DUBss

The firsst four classes in this grroup are knoown to be ccysteine pro
oteases, whicch all
have a similaar catalytic mechanism
m
where a nuucleophilic cyysteine thio
ol is involved
d in a
caatalytic triad
d. The JAMM group off DUBs are known to be zinc‐dep
pendent metallo‐
proteases, making
m
use of zinc an
nd a
water
w
in theiir catalytic mechanism.
m
The
ziinc is coord
dinated in th
he catalytic site
by three ligands, two residues which
w
may
m be a histtidine, glutamate, asparrtate,
lyysine,

or

arginine,

and

a

water
w

16
molecule.
m

DUBs also have the
t capabilitty to
bind free ub
biquitin. Ubiquitin generally
binds to DU
UBs via two sites: itss N‐

Figu
ure 1.6 Ubiqu
uitin bound to
UCH337, with ubiq
quitin in oran
nge
and UC
CH37 in lightt blue, the active
site in
n pink and haairpin bindin
ng in
18
yellow
w

6
te
erminal betaa‐hairpin turrn, which en
ncompasses residues 100‐17 on ubiq
quitin, and the C‐
te
erminal tail of
o ubiquitin (Figure 1.6). In UCH37, for examplee, the hairpin
n turn bindss with
th
he distal site
e of UCH, wh
hile the tail binds
b
to the active site o
of the UCH enzyme.17
All DU
UBs contain a catalytic domain,
d
but can also haave several o
other domains in
addition, including but not limited to
o ubiquitin l ike (UBL) do
omains, zinc‐finger ubiquitin‐
pecific protteases (ZnF‐UBP), ub
biquitin‐associated (UB
BA) domain
ns, microtubule‐
sp
in
nteracting an
nd trafficking (MIT) dom
mains, and B‐‐box domain
ns (Figure 1.7). Each DUB will
have a unique
e combinatio
on of these domains.19

Figurre 1.7 Domaiins of UCHs, OTUs, and JJAMMs15

7
1.3

JA
AMM Metallloproteases

JAMM metallo‐pro
oteases act in a distinct catalytic m
manner because they require
th
he presence of zinc to perform
p
cataalysis. All JAM
MM family m
members haave two zincc ions
th
hat are required for acctivity (Figure 1.8). Thee first zinc is structuraal and holdss the
backbone in place, while
e the second
d zinc is at thhe catalytic site of the m
molecule, heeld in
nd a water molecule.
m
Booth the zinc and the watter are neceessary
place by fourr residues an
or catalysis to occur, ass they both actively parrticipate in tthe catalyticc mechanism
m. All
fo
JA
AMM familyy members also have a helical seection that serves to in
nteract with
h the
issoleucine 44 patch of ub
biquitin upon
n binding.15

Figure 1.8 Ide
entifying chaaracteristics of JAMM m etalloproteaases, shown on AMSH‐LP

8
It has been shown that the JAMM family members have a catalytic mechanism
that is similar to that of thermolysin, a metallo‐enzyme that is the product of gram‐
positive bacteria and is responsible for aiding in the hydrolysis of peptide bonds
between two hydrophobic amino acids.20,21 The basic structure has a catalytic zinc held
in place by the two histidine residues and an aspartic acid, with a molecule of water
coordinated between the zinc and the glutamate (Figure 1.9, i).22 When a diubiquitin
substrate is introduced, Glu286 abstracts a proton from the water molecule, creating a
nucleophile that attacks the peptide bond carbonyl of diubiquitin (ii). This creates a
tetrahedral intermediate (iii), which is further stabilized by the nearby residue Ser351.
The proximal ubiquitin acts as the leaving group with a proton transfer (iv), which causes
the tetrahedral intermediate to collapse (v), while the distal ubiquitin is still in
coordination with the zinc. To complete the mechanism and bring Sst2 back to its free
form, a water molecule coordinates with the zinc once again (vi), causing the distal
ubiquitin to disassociate.
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Figure 1.9 Pro
oposed mechanism of th
he JAMM M etallo‐enzym
me AMSH, based on crysstal
sttructures of Sst2 (boxed in intermed
diates have bbeen capturred in crystall structures)22

1.4

AM
MSH

AMSH (Associated Molecule with
w the SH 3 domain o
of STAM) is a 48 kD hu
uman
deubiquitinasse involved in signal traansduction. It functions by binding to the SH3 (SRC
Homology
H
3)
3 domain of STAM (signal
(
trannsducing ad
daptor molecule), a ssignal
trransducing adaptor
a
mollecule that aids
a in cytokkinesis.23 AM
MSH is one of the neceessary
proteins in th
he endosomal sorting co
omplexes re quired for transport (ESSCRT) machiinery,
in
n which the cleavage of diubiquitin acts as a siggnal in a casccade of prottein events.224 Full
le
ength AMSH
H has 3 do
omains thatt span overr 425 resid
dues: the M
MIT (microtu
ubule
in
nteracting an
nd traffickin
ng) domain, the SBM (SSH3 domain binding mo
otif) domain, and
th
he JAMM domain, the last of which is necesssary for cattalysis (Figure 1.10). Closely
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re
elated to AM
MSH are Sstt2, the yeasst orthologuue of AMSH, and AMSH
H‐LP (AMSH like‐
protease), a JAMM famiily member with high ssequence similarity to AMSH. AMSSH‐LP
co
ontains a JA
AMM domain
n, but no MIT or SBM d omain, so iss thought to
o have a diffeerent
fu
unctionality than that off AMSH. Sst2 contains bboth a JAMM
M domain an
nd a SBM do
omain
and is hypoth
hesized to haave an MIT domain, impplying similaar functionallity to AMSH
H. For
dies only th
he JAMM domain (i.e.,, catalytic d
domain) of Sst2, comprising
caatalytic stud
re
esidues 245‐‐435, is need
ded for catallysis to occur.25

Figure 1.1
10 Domain diagram
d
of A
AMSH, AMSH
H‐LP, and Sstt2

CRT
1.4.1 ESC
Endossomal sortin
ng complexe
es required for transport (ESCRT)) machineryy is a
proteins in w
which
biological sysstem that iss responsible for the ddegradation of target p
membrane
m
bound
b
prote
eins are enggulfed into tthe cell by endocytosiss (Figure 1.1
11).26
ESCRT memb
bers recognize proteins to be degrraded by ub
biquitin tags,, and recruiit the
taagged prote
eins to the endosome, which func tions as a ttransport m
medium from
m the

11
plasma membrane to lyssosomes. Mu
ultivesicular bodies are formed around the pro
oteins
by budding and subseque
ently fuse to
o the lysosom
me, where th
he protein iss degraded.

nery26
Figure 1.11 Process of protein degraddation by ESSCRT machin

More specifically,, the ESCRTT complex iss comprised of the follo
owing mach
hinery
omponents: ESCRT‐0, ESCRT‐I,
E
ESC
CRT‐II, and ESCRT‐III ((Figure 1.12
2).27 First, target
co
proteins are ubiquitinatted specifically by K633‐linked polyubiquinateed chains, w
which
heir transpo
ort to the endosome. The individ
dual ESCRT members work
siignal for th
se
equentially in the role of lysosomaal sorting. ESSCRT‐0 is reesponsible for clusteringg the
ubiquitinated
d proteins when
w
they firrst reach thee endosomee and then p
pass the pro
oteins
on to ESCRT‐II. ESCRT‐I recruits ESCRTT‐II, and the two work to
ogether to ccreate memb
brane
buds by bend
ding the membrane and
d ensure thaat the targett protein is contained w
within
he membran
ne bud. To finish the pro
ocess, ESCRTT‐III compon
nents assem
mble near thee bud
th
and act as a catalyst for vesicle scisssion. From tthere, the vesicles are aable to fuse with
th
he lysosome
e, resulting in
n destructio
on of their coontents.28
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AMSH
H functions in this patthway to deeubiquitinatte the carggo prior to their
destruction so
s that ubiq
quitin can be
b recycled and reuseed. ESCRT‐IIII members have
binding dom
mains speciffic to AMSH and USPP8, anotherr DUB thatt functions with
endocytotic sorting
s
pathw
ways, which
h deubiquitinnate the pro
oteins beforee budding occcurs.
AMSH
A
is onlyy able to cleave K63‐linkked polyubiqquitin chainss, while USP
P8 does not have
any chain typ
pe specificityy, so the reaasons why tthese two sp
pecific DUBss are recruitted is
n is why ESC
CRT‐0 is funcctionally able to recruit both AMSH
H and
unknown. Alsso unknown
USP8.
U
It has been proposed thaat AMSH iss responsib
ble for chaain trimmin
ng of
polyubiquitin
n in the early stages of the ESCRT machinery sso the proteein can be eeasily
passed alongg between ESCRT‐0,
E
I, and
a II, but nno concrete data has beeen produceed to
29
co
onfirm this hypothesis.
h

Figure 1.12 Mu
ultivesicular body formattion by the EESCRT machinery27
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1.4.2 Sstt2
Sst2 is
i the fissio
on yeast (Sa
accharomycces cerevisiaae) orthologgue of AMSSH. It
sh
hares a 40%
% sequence homology
h
with AMSH annd shows co
onservation of structuraal and
caatalytic resid
dues (Figure
e 1.13). Like all JAMM m
metallo‐proteeases, Sst2 ccontains two
o zinc
io
ons, one ressponsible for catalysis and
a the otheer that main
ntains structural integrity of
th
he protein.300 The structu
ural zinc in Sst2 is held innto place byy His356, Cyss397, His404
4, and
His406
H
while the catalytic zinc is held
d in place byy His341, His343, and A
Asp354, as w
well as
a water that is held in plaace by Glu28
86. It has beeen previoussly determined that muttating
Asp354
A
and Glu286 to alanine
a
in th
he same connstruct resu
ults in a cataalytically inaactive
mutant
m
incap
pable of cleaavage of diubiquitin, connfirming thee importancee of the residues
th
hat hold th
he zinc in place
p
as we
ell as the important rrole of thee catalytic w
water
22
molecule.
m

Figure 1.13
3 Overlay of the
t catalyticc domains off Sst2 and AM
MSH, with close‐ups of tthe
active site
s and struuctural zinc
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1.4.3 Mobile Looop of Sst2
In reccent studiess of Sst2, several
s
form
ms of Sst2 (Sst2 free,, Sst2 boun
nd to
diubiquitin, Sst2
S
bound to monoubiquitin, andd Sst2 Glu2886Ala) were crystallized
d and
exxamined.22 Upon
U
overlaaying the diffferent structtures, it wass noted thatt residues Leeu402
and Phe403 are
a relativelly mobile, opening and closing alm
most like a hinge across from
Asp315
A
and Thr316
T
(Figu
ure 1.14). To
ogether, thiss group of rresidues seems to be ab
ble to
block or allow
w access to the
t active siite residues,, having the potential to
o impact thee rate
att which cataalysis is able
e to occur. It seems thaat the abilityy of Phe403
3 to interact with
Asp315
A
acrosss the activve‐site cleft may contriibute to thee flap dynamics, as weell as
co
ontribute ke
ey interactio
ons with the Lys63 side ggroup of thee proximal ubiquitin enggaged
in
n the isopepttide bond.

Figure 1.14 The mobile loop of Sst2, comprised of residues Phe403 and
d Leu402 sho
own
acrosss the loop fro
om resides A
Asp315 and Thr316.22
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In order to better understand the role of the mobile loop in catalysis, mutations
were introduced into Sst2’s mobile loop. The goal of making the loop either more rigid
or more flexible was to examine the effect of these mutations on catalysis, structure,
and other biophysical properties. For more rigidification, a Phe403Trp mutation was
chosen, as tryptophan is similarly hydrophobic but is bulkier and could allow increased
contacts with residues across the loop. A Phe403Ala mutation was also constructed with
the goal that loop interactions would be lost.
To explore the effect of each mutant, both structural and biophysical methods
were utilized. First, through crystallization of both the free and ubiquitin bound mutants,
we hope to compare the conformation of the mobile loop residues to the previously
published wild type structure to see if any differences in contacts or orientation of side
chains can be seen. In terms of biophysical studies, we have determined kinetic kcat and
KM values, structural stability by circular dichroism (CD), binding affinity by isothermal
titration calorimetry (ITC), and determined cleavage efficiency of K63, K48, and K11‐
linked diubiquitin by the mutants. With this combination of experimental studies, we
hope to better understand the role of the active‐site flap in catalysis in the AMSH
system.
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CHAPTTER 2.

2.1

METTHODS

Cloning, Mutagenesis,
M
and Purificaation

To pre
epare the Ssst2 construcct, Sst2cat waas cloned intto the pGEX
X‐6P‐1 vecto
or,
exxpressed in
n Rosetta cells,
c
and purified
p
by glutathionee (GST) purification, aas
described bellow.

2.1
1.1 Cloningg of Sst2cat innto pGEX‐6PP‐1
Full le
ength Sst2 was
w amplified by the poolymerase ch
hain reaction
n (PCR) usin
ng
an S. pombe cDNA libraryy (a gift from
m K. Gould, V
Vanderbilt U
University, N
Nashville, TN
N).
The catalytic domain of
Ssst2 (residues 245−435),
hereafter refferred to as
Ssst2cat, was cloned
c
into
th
he pGEX‐6P
P‐1 vector
between

cut
c

sites

BamHI and XhoI using
sttandard

cloning

protocols (Figgure 2.1).1

Figure 2.1 Vector maap of pGEX‐6
6P‐1, with
cut sittes BamHI aand XhoI indicated
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Forwaard and reve
erse primers were desig ned for clon
ning of Sst2caat into pGEX‐6P‐1
(A
Appendix). Insert PCR was
w done by mixing 2 µLL template ffull length Ssst2, 1 µL forrward
primer (dilute
ed 1:10), 1 µL
µ reverse primer
p
(dilutted 1:10), an
nd 16 µL water in a PCR
R pre‐
mix
m tube (Bio
oneer). Mixttures were run throughh a BioRad TThermocycleer and succeessful
PCR was conffirmed by visualizing the 0.6 kb inssert size on an agarose gel (Figure 2.2 A
ed on the pproduct to rremove exccess primerss and
and B). PCR cleanup waas performe
DNTPs
D
(Quiaggen, QUIprep
p Spin Minip
prep Kit) usinng the manu
ufacturer’s p
protocol.2

Figure
F
2.2 Inssert PCR of Sst2
S cat (A) Th
hermocyclerr settings to allow for DN
NA denaturaation,
annealing,
a
and
a extension (B) DNA ge
el of the PCR
R product, sh
howing the SSst2 cat ban
nd at
0.6kb

or. A
A dige
estion was done
d
of both
h the cleanedd‐up insert aand the pGEEX‐6P‐1 vecto
master
m
mix was
w made containing
c
re
estriction ennzymes Bam
mHI and Xho
oI (New Enggland
Biolabs), NEB
B Buffer3 (New England Biolabs), annd BSA. Vector and inseert samples were
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mixed
m
in 30
0 and 10 μL
μ volumes,, respectiveely, in 2.3:11 ratios of master mix to
ve
ector/insert and incubatted at 37oC for
f 4 hours tto cut the do
ouble strand
ded DNA in o
order
to
o form 3’‐hyydroxyl and 5’‐phosphate
5
e groups. PC
CR cleanup w
was again peerformed on both
saamples prior to the dige
ested vectorr and insert being ligateed together by the 3’ and 5’
ends in an ATP
A depend
dent reaction. Insert DN
NA, vector DNA, T4 DNA ligase b
buffer
A
and T4
4 DNA ligase (New Englaand Biolabs) were mixed
d and allowed to
(ccontaining ATP),
re
eact overnigght at room temperature. Resultingg DNA was transformed into DH5α
αcells
and mini‐prep
pped to obtaain amplified
d DNA.
A testt digestion was
w done to ensure tha t the desired insert wass cloned into the
ector. Appro
oximately a 1:1 ratio off master mi x to mini‐prrepped DNA
A was mixed
d and
ve
in
ncubated at 37o for 3 ho
ours. Successful cloning was confirm
med by runn
ning a DNA ggel of
th
his sample and
a visualizin
ng both the pGEX‐6P‐1 vector at 5 kB and the Sst2 cat inseert at
0.6 kB (Figurre 2.3) Reco
ombinant DN
NA of Sst2caat was transformed into
o Escherichia
a coli
Rosetta cells to be exprressed as a protein with a glutathiione S‐transsferase (GSTT) tag
used to its N‐termini.
fu

Figure 2..3 DNA gel of
o successful cloning of SSst2cat (0.6 kb) into pGEX
X‐6p‐1 (5 kb))
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2.1.2 Sm
mall Scale So
olubility and Expression TTest of Sst2ccat
Before
e the newlyy cloned Sstt2cat construuct was useed for mutaagenesis, a small
sccale solubility and exprression test was perforrmed. An overnight culture was m
made,
co
omposed off 5 mL LB (Lu
uria Broth), 5 μL ampici llin, and onee colony of SSst2cat, shakken at
37oC overnigh
ht for 16‐18 hours. The next morninng, two fresh cultures w
were started
d with
μ ampicillin, and 50 μLL of the ove rnight culture, and allo
owed to incu
ubate
5 mL LB, 5 μL
haking at 37
7oC for 4 hou
urs.
sh
After 4 hours, 300
0 µL of 1 M IPTG
I
was addded to one tube to indu
uce expression (I,
nduced) butt not the other
o
(U, Uninduced) aand the tub
bes were allowed to sshake
In
overnight at 18oC. The next day, the
e induced sample was sp
pun down, rresuspended
d in 1
mL
m phosphatte‐buffered saline (PBS) containing 400 mM KC
Cl and soniccated to lysee the
ce
ells. The lysaate was spun down to pellet
p
excesss cellular debris and a saample was ttaken
frrom the solu
ution (S, Solubility test) to confirm that the pro
otein was so
oluble in solution
(FFigure 2.4).

Figure 2.4 Solubility/Expresssion test off Sst2cat
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2.1
1.3 Mutagenesis of Sstt2cat and AM
MSH‐LP
Variou
us mutation
ns (Table 2.1
1) were introoduced indiividually into
o the Sst2cat and
AMSH‐LP
A
con
nstructs by site‐directe
ed mutagen esis following a standaard mutageenesis
protocol.3,4 Forward
F
and
d reverse primers
p
weree designed for each d
desired consstruct
(A
Appendix) and PCR was done by mixing 1 μLL Sst2cat, 1 μL relevantt forward primer
(d
diluted 1:10)), 1 μL relevaant reverse primer (diluuted 1:10), and 16 μL waater in a PCR
R pre‐
mix
m tube (Bio
oneer). Samp
ples were ru
un through a Thermocyycler as desccribed previo
ously,
and 1 μL Dpn
nI was added
d to the resu
ulting mixturre and incub
bated at 37oC for 2.5 hou
urs to
e DNA and leeave only the newly form
med PCR pro
oduct.
digest all of the methylatted template
NA was transsformed intto DH5‐alph a cells, and
d mutations were confirmed
Resulting DN
with
w by Purdue’s DNA se
equencing faacility. Succeessful mutattions were ttransformed
d into
Rosetta cells and solubility and expression was cconfirmed fo
or each construct beforre full
sccale purificaation (Cys39
97Ala and Phe403Ala mutants were prepareed by other lab
members).
m

Table 2.1 Mutan
nts made forr Sst2 and AMSH‐LP
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2.1.4 S‐Glutathione (GST) Purification
Six liters of Luria‐Bertani cultures for each construct were grown at 37oC until the
optical density reached 0.4 – 0.6 at 600 nm. Flasks were treated with 0.1 mM isopropyl
β‐D‐1‐thiogalactoside (IPTG) to allow for expression of the protein and then were
allowed to incubate overnight at 18oC. The following day, the cells were pelleted by
centrifugation at 5000xg for 8 minutes at 4oC and resuspended in PBS. Lysozyme was
added to the resuspended cells and allowed to sit on ice for thirty minutes, followed by
lysing of the cell suspension with a French press. The lysate was centrifuged at 100,000g
for 1 hour at 4oC to remove all cellular debris. The GST‐tagged protein was purified with
a glutathione‐Sepharose column (GE Biosciences) using the manufacturer’s protocol and
the GST‐tag was removed with PreScission protease (GE Biosciences).
Further purification was performed using size exclusion chromatography (SEC) in
a buffer of 50 mM NaCl, 50 mM Tris‐HCl (pH 7.6), and 1 mM DTT with a Superdex S75
column (GE Biosciences). Proteins were concentrated down, final concentrations
determined spectrophotometrically at 280 nm, and proteins were stored at ‐80oC after
being flash frozen. Full scale GST purifications completed include WT Sst2cat (Figure 2.5),
Sst2 Thr316Ala (Figure 2.6), Sst2 Phe403Trp (Figure 2.7) and AMSH‐LP Phe407Trp
(Figure 2.8).
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Figure 2.5 Pu
urification off Sst2cat (A) 6L
6 expressioon flasks and purification
n gel, resultin
ng in
cat
a 19 kD prottein (B) FLPC
C of Sst2 (C
C) Gel of FPLLC fractions, in which fraactions C4 to
o D6
werre collected and concentrated, resulting in 1mLL of 575 μM p
protein
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Figure 2.6
6 Purification of Sst2 T316A (A) 6L eexpression flaasks and purification gel,
resulting in
n a 19 kD pro
otein (B) FLP
PC of Sst2 T3316A (C) Gel of FPLC fracctions, in which
fractions C8
C to D5 were collected and concenntrated, resu
ulting in 800 μL of 132 μM
protein
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Figure 2.7
7 Purification
n of Sst2 F40
03W (A) 6L eexpression fllasks and pu
urification geel,
resulting in a 19 kD pro
otein (B) FLPC
C of Sst2 F4003W (C) Gel of FPLC fracctions, in wh
hich
fractions C1
12 to D10 were collected and conceentrated, ressulting in 800
0 μL of 233 μ
μM
protein
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Figure 2.8 Purification of
o AMSH‐LP F407W
F
(A) 66L expression
n flasks and purification gel,
resulting in
n a 19 kD pro
otein (B) FLP
PC of AMSH‐‐LP F407W (C
C) Gel of FPLLC fractions,, in
which fractions C1 to C9
9 were collected and concentrated, resulting in 1 mL of 17 m
mM
protein
p
(D) Verification
V
of
o AMSH‐LP F407W puriity, running the concenttrated sample as
well as thre
ee dilutions, showing de
ecent purity with some aaggregation around 200 kD
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2.2
2

Crystallization andd Data Collecction

All cryystallization was performed at rooom temperaature by sittting drop vvapor
diffusion. Cryystals of Sstt2 F403W were
w
grown from moth
her liquor ccontaining 0
0.2 M
ammonium tartrate
t
dib
basic (pH 7..0) and 20%
% (w/v) polyethylene glycol 3350
0 and
atttained maxximum size in 5‐7 days. To
T prepare a complex o
of Sst2 F403W and ubiquitin,
Ssst2 F403W and ubiquitin were mixed
m
at a rratio of 1.5:1. Crystals of the com
mplex
(SSst2F403W‐U
Ub) formed in 2‐5 days in 0.04 M Citric acid, 00.06 M Bis‐TTRIS propan
ne pH
6.4, 20% w/vv PEG 3350. Retention of
o the compllex in crystaals was verified by looping of
other liquor, dissolving the crystals in SDS P
PAGE bufferr and
crrystals, wasshing in mo
ru
unning them
m on a proteiin gel, follow
wed by silverr staining.
Crystaals were soaaked briefly in a cryoprootectant solu
ution of 25%
% ethylene gglycol
and flash frozen with liquid nitrogen
n. X‐ray diffrraction dataa for all desccribed consttructs
was
w collected
d at 100 K using a Mar300
M
CCD detector aat beamline 23 ID‐B att the
Advanced
A
Photon Source
e at Argonne
e National Laaboratory in
n Argonne, IL (Figure 2.9
9). All
data was processed with HKL3000.5

Figure 2.9
2 Beamline
e 23 ID‐B at Argonne Naational Labs
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2.2.1 Structural Determination and Refinement of Sst2 F403W in free form
One crystal structure was obtained for Sst2 F403W in the space group P21 that
diffracted to 1.6 Å. Data was collected and the structure was determined by MolRep6
molecular replacement in the CCP4 suite7 using the catalytic domain of Sst28 (PDB file
4JXE) as a search model. Initial refinement was done in Refmac59 using rigid body
refinement and then restrained refinement. A model was built using Coot10 and
subsequent rounds of refinement were done in PHENIX11,12 and CCP4, ultimately
yielding an Rwork of 17.0% and Rfree of 19.9%. TLS13,14 was used during refinement with
the entire asymmetric unit taken as one TLS group.

2.2.2 Structural Determination and Refinement of Sst2 F403W‐Ub
One crystal structure was obtained for Sst2 F403W bound to ubiquitin in the
space group P212121 that diffracted to 2.3 Å. Data was collected and the structure was
determined by MolRep6 molecular replacement in the CCP47 suite using the catalytic
domain of Sst2 bound to ubiquitin8 (PBD file 4MSQ) as a search model. Initial refinement
was done in Refmac59 using rigid body refinement and then restrained refinement. A
model was built using Coot10 and subsequent rounds of refinement were done in
PHENIX11,12 and CCP4, ultimately yielding an Rwork of 18.92% and Rfree of 23.25%. TLS13,14
was used during refinement with the entire asymmetric unit taken as one TLS group.
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2.3

Determination of Kinetic Parameters

Kinetic values of diubiquitin cleavage were determined by calculation of initial
velocity parameters.15 Proper enzyme concentrations to be used in the assay were
determined by incubating varying concentrations of enzyme with 49.5 μM K63‐linked
diubiquitin for 7.5 and 15 minutes to see which concentrations showed quantifiable
cleavage. Once determined, the enzyme (25 nM Sst2cat, 100 nM Sst2 F403W, 2 µM Sst2
C397A, and 100 nM AMSH‐LP F407W) was incubated in a reaction of 50 mM Tris‐HCl (pH
7.0), 20 mM KCl, 5 mM MgCl2, and 1 mM DTT with 20, 40, 77, and 99.5 μM
concentrations of diubiquitin. Reactions were allowed to occur at room temperature for
7.5 minutes (wild type) and 15 minutes (mutants) before being quenched with SDS‐
PAGE sample buffer to determine initial velocity measurements.
Samples were loaded and run on an SDS‐PAGE gel along with 6, 20, and 40 μM
ubiquitin standards. Ubiquitin bands were quantified and integrated using ImageJ16 and
plotted with a calibration plot of standards in order to determine the amount of
ubiquitin produced through the cleavage of diubiquitin. All generated data was analyzed
with KaleidaGraph and fit to the following equation to determine kcat and KM:

Vi = (Vmax[S])/(KM + [S])

Eq. 2.1

where Vi is the reaction rate, Vmax is the maximum velocity achieved by the system, [S] is
the concentration of substrate, and KM is the amount of substrate necessary to reach
half the value of Vmax.
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2.4

Circular Diichroism

Circularr Dichroism (CD) is a tecchnique thatt determinees the secondary structu
ure of
a protein byy utilizing th
he propertie
es of right and left haanded polarrized light. This
te
echnique shows if a pro
otein has be
eta‐sheets, is alpha‐helical, extendeed, or denattured
by plotting molar
m
ellipticcity as a function of w
wavelength ((Figure 2.10
0 A).17 Addittional
nformation can
c be gleaned by a th
hermal meltt, when the ratio of follded to unfo
olded
in
protein is measured as a function of temperature and iintermediates formed upon
melting
m
can be
b visualized
d by variation
ns in the meelting curve ((Figure 2.10 B).

Figure
F
2.10 Circular
C
Dichroism (A) De
epiction of thhe characteristic shapess of CD reado
outs,
17
including alpha‐helices and beta sheets (B) Deepiction of a thermal meelt, showing the
unfolding of various constructs ass temperature increasess18
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2.4.1 Circular Dichroism Parameters
The secondary structure of the Sst2 constructs was determined using circular
dichroism. Protein samples of 0.2 mg/mL were used diluted in 100 mM phosphate
buffer (pH 7.4). Structure of the proteins was monitored by circular dichroism at 20oC
over a range of 190–280 nM. Spectra were recorded in a Jasco J‐810 spectropolarimeter
in the far‐UV region using a cuvette with a path length of 0.1 cM. Each spectrum was
composed of an average of four scans (speed scan of 100 nm/min) and corrected with a
subtraction of phosphate buffer alone. Mean residue molar ellipticity was calculated for
each sample using the following equation:

[θ] = (θ x 100M)/(Cln)

Eq. 2.2

where θ is the ellipticity in degrees, l is the path length in centimeters, C is the
concentration is mg/mL, M is molecular mass, and n is the total number of residues in
the protein. Calculated mean residue molar ellipticity is given in degcm2decmol‐1 and
was plotted as a function of wavelength in nm.
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2.4.2 Thermal Melt Parameters
Protein stability was measured using the thermal melt function of the Jasco J‐810
spectropolarimeter with protein at a concentration of 0.2 mg/mL diluted in phosphate
buffer. Structure was monitored over a range of 20oc to 86oC with a temperature
gradient of 0.5oC/min and data was recorded every 2oC at 222 nm. Spectrum at each
temperature interval was composed of an average of four scans and corrected with a
subtraction of a spectrum of phosphate buffer alone. Percent folding at each
temperature was calculated for each sample using the following equation:

fu = (yf – y222)/(yf – yu)

Eq. 2.3

where fu is fraction unfolded, yf is the value at 20oC when 100% of the protein is folded,
yu is the value at 86oC when 100% of the protein is unfolded, and y222 is the value of the
signal at 222λ at each temperature interval. Percentage of protein folded was plotted as
a function of temperature and unfolding curves were analyzed to determine TM for each
protein.
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2.5

Isothe
ermal Titratiion Calorimeetry

Isothermal Titration Calorimetrry (ITC) is ann analytical ttool used to quantify bin
nding
afffinity of a protein
p
and ligand by measure
m
of hheat given o
off in a reacttion cell verrsus a
re
eference celll (Figure 2.1
11 A). From the measurre of heat giiven off over time, enth
halpy,
entropy, and the disassocciation consttant can be determined (Figure 2.11
1 B).

orimetry (A) General set‐‐up of an ITC
C experimen
nt (B)
Figure 2.11 Issothermal Tiitration Calo
Example
e readout off an ITC expe
eriment, as w
well as how to calculate the various
paarameters gleaned from the experim
ment19

2.5.1 Isothermal Titration Caalorimetry Parameters
ITC exxperiments were
w
carried
d out at 25oC in order to
o quantify the binding afffinity
m
with
h ubiquitin using
u
a GE/M
MicroCal ITC2200 calorimeter. The pro
oteins
of the Sst2 mutants
were
w
dialyzed
d overnight in a buffer of
o 50mM Triis‐HCl (pH 7.6) and 50m
mM NaCl thatt was
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exchanged four times. 500 µM ubiquitin was titrated into a 50 µM solution of protein.
22 injections with 1.4 µL Ub/injection were done for the experiment. 180 seconds was
allowed between each injection to make sure that baseline was reached before the next
injection. Baseline correction was performed by NITPIC20 and analyzed using a one site
model from SEDPHAT21.

2.6

Diubiquitin Cleavage Assay

A diubiquitin cleavage assay was performed to using Sst2cat, Sst2 F043W, and
Sst2 F403A and K11, K48, and K63‐linked diubiquitin. The enzyme (250 nM Sst2cat, Sst2
F403W, Sst2 F403A, and Sst2 T316A) was incubated in a reaction of 50 mM Tris‐HCl (pH
7.0), 20 mM KCl, 5 mM MgCl2, and 1 mM DTT with concentrations of 20 μM
concentrations of K63, K48, and K11‐linked diubiquitin. Reactions were allowed to occur
at room temperature for 5 hours before being quenched with 5X SDS‐PAGE sample
buffer. Samples were loaded and run on an SDS‐PAGE gel and diubiquitin and
monoubiquitin bands were quantified with ImageJ.15 Monoubiquitin to diubiquitin ratios
were determined for each sample, and trials were repeated in triplicate with standard
deviations determined for each sample.
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CHAPTER 3.

3.1
1

CRYSTA
ALLOGRAPH
HY

Crystalli zation

3.1.1 Cryystallization oof Sst2 F4033W
Crystaallization of Sst2 F403W
W in free foorm was pursued with the protein at a
co
oncentration
n of 314 μM
M in screenin
ng conditionss PEG/ION I & 2 (Hamptton HR2‐126
6 and
HR2‐098)
H
and
d Crystal Scrreen I & II (H
Hampton HR
R2‐110 and H
HR2‐112). Affter 1 to 11 days,
15 conditionss resulted in the growth of crystals ((summarized
d in Table 3.1). Many cryystals
were
w
small and
a thin in size, but four conditionns resulted in larger crrystals that were
re
ecreated (bo
olded in Tab
ble 3.1). Fre
esh crystals from the fo
our desired conditions were
ndition G6 giving the best
taaken to Syn
nchrotron, with a crysstal from PPEG/ION con
re
esolution at 1.8 Å when shot with a 20 μM micr obeam (Figu
ure 3.1)

Figure
F
3.1 Sst2 F403W crrystal in a 0.1mM loop, ccrystalized in
monium tarttrate
n 0.2 M Amm
dibasic pH
H 7.0, 20% w
w/v PEG 3,3550
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Table 3.1 Summary of conditions in which Sst2 F403W crystallized, with conditions that
were pursued further bolded (D8, G6, and H4 in PEG/ION and D1 in Crystal Screen)
Screen
1
2

Condition
D4

PEG/ION
I

D6

3

D8

4

E6

5

E8

6

F4

7

F6

8

F9

9

PEG/ION
II

F12

10

G6

12

G9

13

G10

14

H3

15

H4

16

Crystal
Screen I

D1

Mother Liquor Components
0.2 M Sodium phosphate dibasic dehydrate,
20% w/v PEG 3,350
0.2 M Potassium phosphate dibasic,
20% w/v PEG 3,350
0.2 M Ammonium phosphate dibasic,
20% w/v PEG 3,350
0.2 M Sodium malonate pH 6.0,
20% w/v PEG 3,350
0.2 M Sodium malonate pH 7.0,
20% w/v PEG 3,350
8% v/v Tacsimate pH 7.0,
20% w/v PEG 3,350
8% v/v Tacsimate pH 8.0,
20% w/v PEG 3,350
0.1 M Ammonium citrate tribasic pH 7.0,
20% PEG 3,350
0.2 M DL‐Malic acid pH 7.0,
20% PEG 3,350
0.3 M Ammonium tartrate dibasic pH 7.0,
20% w/v PEG 3,350
2% v/v Tacsimate pH 6.0,
0.1 M BIS‐TRIS pH 6.5, 20% PEG 3,350
2% v/v Tacsimate pH 7.0,
0.1 M HEPES pH 7.5, 20% w/v PEG 3,350
(0.04 M Citric acid, 0.06 M BIS‐TRIS propane,
pH 6.4), 20% w/v PEG 3,350
(0.03 M Citric acid, 0.07 M BIS‐TRIS propane,
pH 7.6), 20% w/v PEG 3,350
0.1 M HEPES sodium pH 7.5,
2% v/v PEG 3,350, 2.0 M Ammonium sulfate

Days to
crystalize
1
5
2
6
6
6
6
6
11
11
6
2
5
1
5
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3.1.2 Crystallization Sst2 F403W‐Ub
Crystallization of Sst2 F403W bound to ubiquitin was pursued with the protein at
a concentration of 300 μM mixed with a 200 μM concentration of ubiquitin in PEG/ION I
& II crystallization suites (Hampton HR2‐126 and HR2‐098). An excess of Sst2 F403W
was used to prevent free monoubiquitin from crystalizing on its own. After 1 to 12 days,
it was found that 7 conditions resulted in crystals (Table 3.2).

Table 3.2 Summary of conditions in which Sst2 F403W‐Ub crystalized, with conditions
that were pursued further bolded (D4, G10, H3, and H4)

Screen
1
2

Condition
C12

PEG/ION
I

D4

3

D6

4

G10

5

H3

6

7

PEG/ION
II

H4

H12

Mother Liquor Components
2% v/v Tacsimate pH 7.0,
HEPES pH 7.5,
20% w/v PEG 3,350
0.2 M Sodium phosphate dibasic
dehydrate, 20% w/v PEG 3,350
0.4 M Potassium phosphate dibasic,
20% w/v PEG 3,350
2% v/v Tacsimate pH 6.0,
0.1 M BIS‐TRIS propane pH 7.6,
20% PEG 3,350
0.04 M Citric Acid,
0.06 BIS‐TRIS M propane pH 6.4,
20% w/v PEG 3,350
0.03 M Citric Acid,
0.07 M BIS‐TRIS propane pH 7.6,
20% w/v PEG 3,350
1% w/v Tryptone,
0.001 M Sodium azide,
0.05 M HEPES sodium pH 7.0,
20% w/v PEG 3,350

Days to
crystalize
7
12
1
7

7

2

2
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To con
nfirm that the crystalss
were
w
of the complex and not Sst2
2
F4
403W or ub
biquitin alon
ne, a crystal
was
w taken out of condittion H4 and
d
analyzed by SDS‐PAGE with silver
sttaining. Oncce removed,, the crystal
was
w washed three times with fresh
h
mother
m
liquo
or to removve any free
e
protein

still

in

soluttion.

Upon
n

co
ompletion of
o the silverr staining, itt

Figgure 3.2 Silveer stain of Ssst2
F403W‐Ub ccrystal afterr
w
washing 3 tim
mes (W1, W2
2,
and W3), showing the
preesence of Ssst2 F403W and
ubiq
quitin

was
w confirme
ed that the crystal
c
was a
co
omplex

off

Sst2

F4
403W

and
d

monoubiquit
m
in (Figure 3.2).
Most crystals obtained were thin and neeedle‐like in sshape, so an
n additive sccreen
was
w performe
ed (Hampton Additive Screen
S
HR2‐4428). The trray was set u
up with 0.8 μL of
PEG/ION condition D4 (0.2 M Sodium
m phosphatee dibasic deh
hydrate, 20%
% w/v PEG 3
3,350)
0 μL of prrotein compplex, and 0.22 μL of eacch additive, with
ass the mother liquor, 0.8
crrystals forming in 1 to 14
1 days (Tab
ble 3.3). Seveeral of thesee additive co
onditions yieelded
laarger crystals that seeme
ed more con
nducive for ccrystallograp
phic data colllection.
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Table 3.3 Summary
S
of additive con
nditions in w
which Sst2 F4403W‐Ub cryystallized, w
with
con
nditions yield
ding larger crystals
c
boldeed (B2, C5, D
D1, D3, D4, aand E5)

1
2
3
4
5
6
7
8
9
10
11
12

Co
ondition

Additive coomponent

A1
A10
B2
C2
C5
C10
D1
D3
D4
E5
F10
G9

0.1 M Barium chlooride dehydrate
0.1 M Zinc chloride
0.1 M Prasseodymium (III) acetatee hydrate
0.1 M L‐PProline
0.1
0 M Sodium
m bromide
1.0 M G
Glycine
0.1 M Betaine h
hydrochlorid
de
0.1 M Spermine
S
tettrahydrochlloride
0.1 M he
exammine ccobalt (III) ch
hloride
10% w/v P
PEG 3,350
5%
5 w/v n‐Do
odecyl‐N,N‐ddimethylamine‐N‐oxide
30% w/v 1,44‐Dioxane

Days to
crystalize
1
4
1
11
14
4
7
8
2
4
1
7

Fresh crystals
c
were
e obtained in the initial PEG/ION sccreen of con
nditions D1, G10,
and H3, with needle‐like crystals fro
om PEG/ION condition H
H3 giving thee best resolution
att 2.3 Å when
n shot with a 20 μM miccrobeam (Figgure 3.3).

Figure 3.3 Sstt2 F403W‐Ub crystal in a 0.1mM looop, crystalizeed in (0.04 M Citric acid,, 0.06
M BISS‐TRIS propaane, pH 6.4),, 20% w/v PEG 3,350
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Crystaals from the
e additive sccreen were also looped
d and taken to Synchro
otron.
Tw
wo data se
ets were co
ollected from
m crystals oof additive screen D1 (0.1 M beetaine
hydrochloride
e), but both yielded a lo
ower resolu tion than th
he previously collected 2.3 Å
data. Unforttunately, most of the larger crystals from the additive sscreen weree salt
crrystals. Upon inspection
n while beingg shot with tthe microbeeam, the crysstals were yeellow
in
n appearance (Figure 3.4
4 A) and fiellded a diffraaction patterrn typical off that of saltt with
sp
poradic, mid
d/high resolu
ution spots (Figure 3.4 B
B).

Figure
e 3.4 Salt cryystal from ad
dditive screeen (A) Salt cryystal in a 0.1
1mM loop
(B)
( Diffractio
on pattern oof the salt cryystal
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3.2

Structural
S
Paarameters

3.2.1 Structure
S
of Sst2 F403W
W
The 1.8
1 Å crystalls of Sst2 F4
403W crystaalized in thee space group P21 with
h two
molecules
m
in the asymme
etric unit (Figure 3.5). Fiinal Rwork and Rfree were 0.170 and 0
0.199,
re
espectively, and depositted in the Protein Data B
Bank (PDB) u
under accesssion code 4ZZD4.

metric unit of
o Sst2 F403W, compriseed of Chainss A and B
Figurre 3.5 Asymm
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3.2.2 Strructure of Ssst2 F403W‐U
Ub
The 2.3 Å crystalss of Sst2 F40
03W‐Ub crysstalized in th
he space gro
oup P212121 with
tw
wo protein complexes (each comprised of Ssst2 F403W and monou
ubiquitin) in
n the
assymmetric unit
u (Figure 3.6).
3
Final Rwork
and Rfree were 0.189 and 0.232, rrespectivelyy.
w

A
unit of Sst2 F403W bou nd to ubiquitin, comprissed of Chain
ns A
Figure 3.6 Asymmetric
and B, with
h Sst2 F403W
W shown in green
g
and bllue and ubiq
quitin shown
n in orange aand
yellow
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3.2.3 Crystallographic Parameters

Table 3.4 Summary of Sst2 F403W Crystallographic Parameters

DATA COLLECTION
Space Group
Cell Dimensions
a, b, c (Å)
α, β, γ (deg)
Resolution (Å)
Rmerge (%)
I/δI
Completeness (%)
Redundancy
REFINEMENT
Resolution (Å)
No. of reflections
Rwork/Rfree
No. of atoms
Protein
Ion
Water
rmsd
Bond lengths (Å)
Bond angels (deg)
Average B factor (Å)
Protein
Ion
Water
Ligand

Sst2 F403W

Sst2 F403W
bound to ubiquitin

P21

P212121

58.636, 73.697, 64.633
90.0 , 113.5, 90.0
59.44 ‐ 1.63
9.5 (56.2)
18.01 (2.5)
97.6 (96.2)
7.7 (7.7)

56.82, 89.397,117.82
90.0, 90.0, 90.0
71.22 – 2.30
9.7 (45.6)
13.66 (1.67)
100.0 (100.0)
14.6 (13.8)

1.63
62,609
17.0/19.9

2.3
27,239
18.9/23.2

3034
4
215

4127
4
90

0.007
1.142

0.009
1.164

23.33
20.073
31.838
41.927

46.03
42.987
42.890
44.987
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3.3

Crystallographic Analysis

Once crystallographic models were established for both Sst2 F403W and Sst2
F403W bound to ubiquitin, each was superimposed with wild type models to examine
the loop more closely. Structural integrity of the mutants was verified by confirming the
overall structure of the mutants compared to wild type, specifically the presence of both
zincs ions. The mobile loop residue positioning was examined, and the free and bound
mutant structures were modeled on top of Sst2 bound to diubiquitin to model the
alignment of the isopeptide bond with the mobile loop.

3.3.1 Confirmation of Structural Integrity
To ensure that the overall structural integrity was retained in the ubiquitin
bound and unbound Sst2 F403W, the structural and catalytic zinc sites were compared
to that of wild type Sst2cat. The catalytic zinc of Sst2cat is held in place by residues His341,
and His343, and Asp354 and a catalytic water oriented by residue Glu286 (Figure 3.7 A).
In both the tryptophan mutant structures, the catalytic zincs were unchanged (Figure
3.7 C and E). The structural zinc of Sst2cat is held into place by Cys397, His356, His404,
and His406 (Figure 3.7 B), which is also unchanged in both mutant structures (Figure 3.7
D and F). This retention of these zinc sites, and the overall structure of the mutants,
indicates that any changes in studies moving forward are an effect of the mutation itself
and not an artifact of a structural change to the protein as a whole.
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Figure
F
3.7 Th
he structural and catalytic zincs of Ssst2cat, F403W
W free, and FF403W boun
nd to
cat
cat
ubiquitin
u
(A) Catalytic zin
nc of Sst2 (B) Structuraal zinc of Sstt2 (C) Cataalytic zinc of Sst2
F403W (D
D) Structural zinc of Sst2
2 F403W (E) Structural zinc of Sst2 FF403W‐Ub (FF)
Catalyticc zinc of Sst22 F403W‐Ub
b
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3.3.2 Loop Examination
In the bound and unbound forms of Sst2 F403W, the mobile loop residues
Leu402 and Phe403 in both proteins in the asymmetric unit (termed Chain A and Chain
B) were examined to see if the mobile loop could be captured in a different position
than the mobile loop of Sst2cat. A surface view of each mutant shows that the loop in
both chains of the free Sst2 F403W mutant as well as Sst2cat1 forms a mostly closed
confirmation blocking access to the active site. However, Chain A, Chain B, and the wild
type protein show slight variations in how open the loop is, indicating mobility (Figure
3.8 A‐C). Both Sst2 F403W‐Ub and Sst2cat‐Ub1 indicate a more open form, allowing room
for the isopeptide bond of diubiquitin to be properly aligned for cleavage (Figure 3.8 D‐
F).
Looking at the individual loop residues show mobility as well, with somewhat
weak electron density around the tryptophan side chain, consistent with increased
flexibility of the flap in the mutant (Figure 3.9). Additionally, the SSt2 F403W free
structure shows the tryptophan residue oriented away from Asp315 and Thr316 across
the loop, while the Sst2 F403W ubiquitin bound structure shows the tryptophan residue
oriented towards those same residues (Figure 3.10), reiterating mobility of the loop.
Examining the orientation of the tryptophan in Sst2 F403W‐Ub in relation to the
phenylalanine of Sst2cat‐Ub reveals that the tryptophan’s placement does not vary much
from phenylalanine, making it unlikely that the tryptophan results in increased
interactions with the substrate as hypothesized (Figure 3.10 B).
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Figure 3.8 Surface
S
reprresentations of the mob ile loop of Sst2 (A) Mobile loop of Sst2
F403W
F
chain
n A (B) Mobile loop of Ssst2 F403W c hain B, show
wn in blue (C
C) Mobile loo
op of
Sst2
S cat, shown in red (D) Mobile loop
p of Sst2cat‐U
Ub, shown in
n blue (E) Mo
obile loop off Sst2
F403W‐Ub chain A (F) Mobile loop of Sst2ccat‐Ub chain B, shown in lime green

Figure 3.9 Electron
E
den
nsity of Sst2 F403W, withh Sst2 F403W
W shown in lime green aand
willd type Sst2 in blue (A) C
Chain A (B) C
Chain B

Figure 3.10
0 Structural aliggnment of Sst2 F403W
F
and Sst2
2 F403W‐Ub witth Sst2cat and Ssst2cat‐Ub (A) An overlay of both chains of
cat
Sst2 F403W over
o
that of Sst2
2 (B) An overlaay of both chain
ns of Sst2 F403W
W‐Ub over that of Sst2cat‐Ub
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3.3.3 Modeling with Diubiquitin bound Sst2
To understand how the tryptophan would align with a diubiquitin substrate,
modeling was done with the mutants and Sst2cat ∆2001 (residues 221‐435) bound to
diubiquitin, as well as free Sst2cat and Sst2cat bound to monoubiquitin (Figure 3.11). In
the free form of Sst2 F403W, the tryptophan is oriented away from the isopeptide bond
of diubiquitin, showing that the unbound mutant protein has flexibility with no
substrate to align with (Figure 3.11 A).
However in the ubiquitin bound form of Sst2 F403W, as seen before, the
tryptophan residue aligns very nicely with phenylalanine of wild type Sst2 (Figure 3.11 B).
Instead of being angled to allow both rings of the tryptophan to make increased
interactions with the isopeptide bond, the aromatic ring of the tryptophan lines up with
the ring of phenylalanine. This again supports idea that the tryptophan is incapable of
making increased contacts across the loop and has little structural difference from that
of wild type Sst2cat.

Figure 3.11 Modeling off Sst2 F403W with Sst2cat and Ssstcat ∆200 (A) Ssst2 F403W mod eled with Sst2caat bound to K63 (B) Sst2
F403W‐Ub
F
modeled with Sst2caat bound to K63
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CHAPTER 4.

4.1

BIOPHYSSICAL ANALYYSIS

Kinetics
K
of Ssst2 F403W

After sttructural anaalysis of Sst2
2 F403W shoowed little ch
hange in thee way the mutant
in
nteracted with the diub
biquitin subsstrate, a kinnetic assay w
was perform
med to see iif the
trryptophan mutation
m
haad an impaact on cataalysis. An initial trial experiment was
performed to
o determine an appropriiate concenttration of Ssst2 F403W to
o be used fo
or the
asssay by using a consttant concen
ntration of K63‐linked diubiquitin
n and increeasing
co
oncentration
ns of Sst2 F4
403W. Meassurable diubbiquitin cleaavage could be seen after 15
minutes
m
at a concentratio
on of 100 nM
M (Figure 4.11), and was used for sub
bsequent asssays.

Figure
F
4.1 Co
oncentration
n determinattion of Sst2 FF403W to bee used for kiinetic assay, with
a conce
entration of 100 nM seleected for furrther assays
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Initial velocity me
easurementts of Sst2 F4403W were determined
d and Michaelis‐
Menten
M
parameters were
e used to de
etermine a k cat of 0.171 + 0.013 s‐1 and a KM of 4
44.0 +
8.1 µM for the
t Sst2 F40
03W mutant, with the assay beingg repeated in triplicatee and
avveraged for increased acccuracy of parameters
p
( Figure 4.2).

Figure 4.2 Sst2 F403W
W cleavage assay
a
resultss, summarizzed by Michaaelis‐Menten
n
param
meters glean
ned from a triplicate
t
gell‐based K63‐‐DiUb cleavaage assay

Obtained kcat and
d KM values were
w
compaared to that of previously published
d wild
tyype Sst2 kine
etic parametters and datta obtained ffrom anotheer lab memb
ber of Sst2 FF403A
(TTable 4.1). In
n both the F403W and F403A
F
const ructs, there was no sign
nificant chan
nge in
KM from thatt of wild tyype, indicatin
ng that oveerall bindingg affinity of the substraate is
unaffected. Both
B
the tryptophan and alanine m
mutants had about a 10‐‐fold decreaase in
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kcat
w type, in
ndicating thhat the rate in which th
he mutants were
c when compared to wild
able to perform catalysis was impaire
ed. The fact that these d
decreases arre observed for a
re
esidue that is not direcctly involved
d in the cat alytic proceess provide further evid
dence
th
hat the mobile loop conttributes to catalysis.
c
A decrease in kcatt for the alanine mutantt was expeccted, as the phenylalanine to
alanine mutation would eliminate
e
the ability with the 403 reesidue to maake contactss with
he isopeptid
de bond off diubiquitin
n. It was orriginally hyp
pothesized that the F4
403W
th
mutant
m
would result in a decrease in kcat due too greater intteractions o
of the trypto
ophan
re
esidue, resu
ulting in prrolonged co
ontact with diubiquitin
n. However,, the previously
mentioned
m
structural
s
an
nalysis rules out this possibility, as it was shown thatt the
trryptophan in
n the mutan
nt structure
e and the phhenylalaninee in the willd type structure
su
uperimpose almost iden
ntically with one anothe r.

e 4.1 Kinetic parameterss of WT Sst2ccat1, Sst2 F4003W, and Sstt2 F403A
Table
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4.2

Circulaar Dichroism
m of Sst2 F4003W

After a dramatic de
ecrease in kcat
n in kinetics, Circular Dicchroism (CD) was
c was seen
performed to
o further con
nfirm the tryyptophan muutant did no
ot cause anyy major backkbone
destabilizatio
on that coulld be contributing to tthe decreasse in activityy. As a point of
co
omparison, the CD of Sst2cat was taken as w
well and plo
otted alongside the mutant
sp
pectrum. Bo
oth showed
d very simillar curves, with minim
mums at 20
08 and 220
0 nm,
in
ndicating an overall alp
pha‐helical shape of thee proteins (Figure 4.3). This once again
re
eiterates thaat the trypto
ophan mutaation did nott cause any major strucctural changges in
th
he protein, so the decrease
d
in kcat is duue to someething otheer than prrotein
destabilizatio
on.

Figure 4.3 Sst2 F4403W CD
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4.2
2.1 Thermaal Melt
A therm
mal melt off the mutan
nt constructt was perfo
ormed in orrder to exaamine
disassociation
n during heating. It waas initially thhought that the potenttial for increeased
in
nteraction across the lo
oop due to the bulkier tryptophan
n residue co
ould stabilizee the
protein and result
r
in an increased
i
melting
m
tempperature. Up
pon completion, it was ffound
hat the wild type and tryptophan mutant
m
had aan almost identical meltting curve (FFigure
th
4.4), indicating there was
w no significant increease in theese interactiions due to
o the
mutation.
m

Figure 4.4 Sst2 F403W
W Thermal Melt
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Additio
onally,

a

sp
pectrum was taken of
o
th
he F403W mutant afte
er
melting
m
at a temperaturre
of 90o and once agaiin
when
w
the temperaturre
was
w returned
d to 20o afte
er
th
he melt, showing thaat

Figuree 4.5 Sst2 F4403W beforee and after m
melt

th
he melting process waas
irrreversible (FFigure 4.5).
Based
d on the ressults from the
t melt, b oth meltingg temperatu
ure (TM) and
d the
222/209 ratio
os were dettermined an
nd comparedd to the vallues of Sst2 F403A and
d wild
tyype Sst2cat (Table
(
4.2). The meltin
ng temperatures and 2222/209 rattios of all tthree
co
onstructs were
w
nearly identical to one anotheer, further ssolidifying that the mu
utants
caaused no inccreased stab
bilization thaat affected m
melting.

Taable 4.2 WT Sst2cat, F403
3W, and F4003A thermal melt param
meters
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4.3

Isothe
ermal Titratiion Calorimeetry

With confirmation
c
n that there
e were no structural changes in the trypto
ophan
mutant,
m
Isoth
hermal Titraation Calorim
metry (ITC) w
was perform
med to try tto substantiate a
re
eason for the decrease in catalytic activity.
a
Sincce structurall and CD datta eliminated the
possibility off increased contacts with
w
the isoopeptide bo
ond, a new hypothesiss was
ormulated; that
t
the rigidified loop could be m
moving moree slowly thaan the wild type
fo
Ssst2cat. If thiss were true,, the producct (monoub iquitin) wou
uld bind bettter, a differrence
th
hat would be manifeste
ed in the dissociation coonstant (KD).. ITC was do
one for both
h Sst2
F4
403W and F403A
F
bindin
ng to monou
ubiquitin annd compared
d to that of wild type. W
When
co
ompared to Sst2cat and Sst2 F403A
A, the tryptoophan mutant has a verry similar KD and
other thermodynamic properties,
p
indicating tthe dissociaation of thee monoubiq
quitin
product is unaffected by the mutatio
on (Table 4.3).

ble 4.3 KD, ∆H,
H and ∆S parrameters fro
om ITC2
Tab
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Figure 4.6 Parameters gle
eaned from ITC (A) Sst2 F403W bind
ding to mono
oubiquitin w
with a
S F403A binding
b
to m onoubiquitin with a KD o
of 6.2 + 0.5 µ
µM
KD of 3.6 + 0.3 µM (B) Sst2
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4.4

Diubiquitin Cleavage Assay

Initially, the tryptophan mutation was constructed under the assumption that it
would rigidify the loop and make it less flexible. After results from a combination of
structural, and biophysical data showed otherwise, our initial assumption was
questioned. Instead of rigidifying the loop and making it less dynamic, what if the
tryptophan mutant made the loop more dynamic? If this was the case, the mutant
would be more promiscuous. Since Sst2 is known to specifically cleave K63‐linked
diubiquitin chains, a cleavage assay was performed with K63‐linked diubiquitin, K48‐
linked diubiquitin, and K11‐linked diubiquitin to see if the mutant was able to better
cleave these chain types. Additionally, since both the tryptophan and alanine mutants
had yielded similar results in all previous biophysical tests, it was thought that a
difference between the two could be visible in their ability to cleave other chain types.
Cleavage of the diubiquitin substrates was allowed to continue for five hours
before being quenched, and cleavage of K11, K48, and K63‐linked diubiquitin by Sst2cat,
Sst2 F403A, and Sst2 F403W was measured and plotted in terms of mono:diubiquitin
ratios (Figure 4.7). The assay was repeated in triplicate to improve accuracy and
standard deviations between trials were calculated (Figure 4.8). Since Sst2cat is known to
cleave K63‐linked chains robustly, this data was omitted in the graphic as cleavage to
monoubiquitin after five hours was nearly 100%.
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Figure 4.7 K6
63, K48, and K11‐linked diubiquitin
d
ccleavage by SSst2cat, Sst2 F403W, and
d Sst2
F403A
F
after 5 hours, witth standard deviations
d
frrom three trrials (K63 cleeavage by Ssst2cat
omiitted as therre is full convversion from
m diubiquitin
n to monoub
biquitin)

Figure 4.8 Gels from thrree trials of K63,
K K48, annd K11‐linked
d diubiquitin
n cleavage asssay
by Sst2
2cat, Sst2 F40
03W, and Sstt2 F403A aftter 5 hours
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A clear trend can be seen when looking at the tryptophan and alanine mutants
(Figure 4.7). In regard to cleavage of K63‐linked diubiquitin, the result is consistent with
previously collected kinetic data, with the tryptophan mutant cleaving K63‐linked
diubiquitin slightly better than the alanine mutant (kcat of 0.163 s‐1 for F403A vs. 0.171
s‐1 of F403W), and both mutants cleaving K63 less robustly than wild type Sst2 (kcat of
1.5 s‐1).
When compared to Sst2cat, the alanine mutant cleaves both K11 and K48 less
robustly. Again, with the hydrophobic interactions lost by replacing phenylalanine with
alanine, this impaired cleavage is expected if the loop is involved in catalysis. If the
tryptophan mutation did indeed make the flap more flexible, it could be reflected in the
enzyme loosing selectivity by showing more activity toward K48 and K11‐linked
diubiquitin substrates than wild type Sst2. Indeed, experimental results indicate the
tryptophan mutant is able to better cleave K11 and K48‐ linked diubiquitin than wild
type Sst2. As previously discussed, Sst2 is specifically able to cleave K63‐linked
diubiquitin chains, primarily due to interactions with the proximal ubiquitin in the
transition state. It should be noted that although we cannot rule out other factors
behind the reduced selectivity with certainty, it seems unlikely that selective
interactions with K11 and K48 are responsible for the loss of selectivity observed K11
and K48‐linked diubiquitin are structurally different. With this in mind, results of the
cleavage assay show a clear distinction between the alanine and tryptophan mutants
and support the hypothesis that the tryptophan mutant is more flexible and that the
point mutation allowed the construct to more readily cleave non‐specific chain types.
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4.5

AMSH‐LP F407W

To see if the trypto
ophan mutattion resultedd in a decreeased kcat in a similar sysstem,
th
he same mu
utation was made in th
he AMSH‐LP construct. Sequence alignment off Sst2
and AMSH‐LP
P shows thaat the corre
esponding coonserved 4003 residue in Sst2 is 407 in
AMSH‐LP,
A
so this was th
he residue th
hat was mutated in thee AMSH‐LP cconstruct (FFigure
4.9).

Figure
F
4.9 Se
equence alignment of AM
MSH family m
members (A
A) Sequence alignment o
of the
mobile
m
loop region
r
of Sstt2 and AMSH
H‐LP (B) Seq uence alignm
ment of the catalytic domain
of AMSSH, AMSH‐LPP, and Sst2
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The cattalytic domaain of AMSH
H‐LP, compriised of resid
dues 231‐436, was used
d as a
co
onstruct for mutagene
esis of phenylalanine 4407 to tryp
ptophan an
nd standard GST
purification was
w carried out. Just as with the Sst2 tryptop
phan mutan
nt, an initiall trial
exxperiment was
w perform
med to determine the beest concentrration of AM
MSH‐LP F407
7W to
be used for cleavage
c
assays by incub
bating increaasing concen
ntrations of the protein
n with
3‐linked diub
biquitin for 15
1 minutes ( Figure 4.10)).
20 μM of K63

Figure 4.10 Concentrration determ
mination of AMSH‐LP F4407W for kin
netics, with a
concentration of 100
0 nM chosenn for further kinetic assay

Throu
ugh use of Im
mageJ, diubiquitin cleavvage could be seen at a concentration of
he Sst2 F403
3W mutant,, so that co
oncentration
n was choseen for
100 nM, justt as with th
ubsequent cleavage
c
asssays. After completion
c
of triplicatee assays, kcaat and KM vvalues
su
were
w
found to be 0.191 + 0.004 s‐1 and 26.5 + 2..3 µM, respeectively (Figu
ure 4.11). A 2008
paper by Sato et.al. exam
mined kinetic parameteers of wild tyype AMSH‐LLP (residues 264‐
436) and AM
MSH‐LP F407A (the equivvalent of Sstt2 F403A) w
with similar gel‐based kiinetic
asssays, so the
ese values were
w
comparred to our geenerated F4007W values.
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Figure 4.11 AMSH‐LP
A
F4
407W cleavage assay ressults, summaarized by Miichaelis‐Men
nten
param
meters glean
ned from a triplicate
t
gell‐based K63‐‐DiUb cleavaage assay

Comp
pared to wild
d type AMSH
H‐LP, the tryyptophan mu
utant had a similar KM, w
while
th
he Kcat was about
a
five times lower, similar
s
to thhe trend seen with the ssame mutatiion in
Ssst2 (Table 4.4, red star)). Additionally, the trypttophan muttant had a sllightly higheer kcat
th
han AMSH‐LLP F407A, aggain mimickking the trennd seen with the Sst2 cconstructs (TTable
4.4, blue starr). These com
mparisons sh
how that th e mobile loo
op’s involvement in catalysis
iss conserved among simillar constructts.

Table 4.4
4 Previously published AMSH‐LP kiinetic data3
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4.6

Additional Looop Mutationss

In addition to changes of the
e Sst2 403 rresidue, add
ditional resid
dues around
d the
mobile
m
loop area were examined, including Thhr316 acrosss from the mobile loop
p and
Cys397 involvved in holdin
ng the structtural zinc in place.

4..6.1 Sst2 TT316A
m
make
es contacts with
w the isoopeptide bon
nd of diubiq
quitin substrrates,
The mobile
but just beyo
ond that are
e residues Asp315
A
and TThr316, whiich the mob
bile loop also
o has
he ability to make contaact with (Figu
ure 4.12). Too see if thesse residues o
opposite thee loop
th
played any part
p
in cataalysis, Thr31
16 was muttated to alaanine to elim
minate poteential
in
nteractions and
a kinetic parameters
p
were
w
soughtt by cleavagee assay.

Figure 4.12 Sst2
S residue
e Thr316 mutated to alannine, shown
n in position across from
m the
mo
obile loop off residues Leeu402 and Phe403
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An inittial trial experiment
e
was perfoormed to determine an approp
priate
co
oncentration
n of Sst2 Th
hr316 to be used by inccubating a constant con
ncentration of 20
μM
μ K63‐linke
ed diubiquitin and conccentrations ffrom 25 nM
M to 500 nM
M of Sst2 Th
hr316
(FFigure 4.13 A).
A When no
o cleavage was
w seen at tthese conceentrations, th
he concentrration
of Sst2 T316
6A was inccreased to range from
m 500 nM to 5 μM (Figure 4.13 B).
Unexpectedly
U
y, again no cleavage
c
wass seen. Becaause the Sst22 Thr316A co
onstruct useed for
asssays had be
een stored at
a ‐80oC for several monnths, there w
was concern
n that the prrotein
had become less active which
w
was why
w it was n ot able to cleave in the assay. How
wever,
when
w
a new protein
p
batcch was made
e and the asssay repeated
d, there wass still no cleaavage
(FFigure 14.3 C).
C

Figure 4.13 Sst2 T316
6A K63‐linke
ed DiUb clea vage assay ((A) Trial 1 (B
B) Trial 2 with
h
in
ncreased con
ncentrationss of Sst2 T31
16A (C) Trial 3 done with
h a fresh battch of Sst2 T3
316A
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The clleavage assaay was repeaated a final ttime with a cconstant con
ncentration
of 20 μM K63
3‐linked diub
biquitin and concentrations of Sst2 T316A rangiing from 5 μ
μM to
20 μM over 15
1 minutes (Figure 4.14
4). Cleavage was visible at concentrrations of 15
5 and
20 μM Sst2 T316A, and was also picked
p
up byy ImageJ at a concentrration of 10
0 μM.
Because such
h a high concentration of the prootein was neeeded to seee any cleavage,
obtaining KM and kcat paraameters wass not pursueed.

Figure 4.14 5‐20 μM concentrations of Sst2 T3116A cleavage of K63‐linkked diubiquiitin,
with
h monoubiqu
uitin areas qquantified byy ImageJ
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Althou
ugh specificc kinetic parameters w
were not ob
btained for the mutantt, the
re
esidue itselff was examiined to see what couldd be altering its activity so profou
undly.
Besides beingg across from the mobiile loop of SSst2, Thr3166 is located in a hairpin
n turn
where
w
it has the potentiaal to create a stabilizing interaction with Thr313
3 (Figure 4.1
15 A).
Itt is hypothesized that by
b mutating Thr316 to alanine (Figgure 4.15 B), this interaaction
co
ould be lost,, destabilizin
ng the protein enough too create a prrofound deccrease in catalytic
activity in the
e mutant.

Figure 4.15 Examination of T316 (A
A) WT Sst2, showing the ability of T3
313 and T316
6 to
create a stabilizing interaaction with one
o another (B) Sst2 T3116A, showingg the mutan
nt has
lost the ab
bility to interract with T3113
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4..6.2 Sst2 C
C397A
A finaal site of inte
erest that was
w examineed was Cys397, one of tthe four residues
re
esponsible for
f holding the
t structuraal zinc in plaace. By muttating this reesidue to alaanine
(FFigure 4.16)), Cys397 sh
hould lose its ability tto make co
ontact with zinc, poten
ntially
destabilizing the protein.

s
zin
nc site of Sstt2, with C3977 mutated to
o alanine
Figure 4.16 The structural

med to deteermine an aappropriate concentratio
on of
A trial experiment was perform
A to be used
d for assays by using a constant co
oncentration
n of 20 μM K63‐
Ssst2 Cys397A
linked diubiq
quitin and concentratio
c
ons increasi ng from to
o 500 nM to 5 μM of Sst2
Cys397A (Figure 4.17). Concentratio
C
ons of 2 andd 5 μM sho
owed cleavage of K63‐liinked
diubiquitin to
o monoubiq
quitin by ImageJ, so a cconcentratio
on of 2 μM was chosen for
su
ubsequent assays.
a
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Figure 4.17
4 Sst2 C3
397A cleavagge of K63‐lin ked diubiquitin at 500 n
nM to 5 μM
concentratio
c
ons, with mo
onoubiquitinn areas quan
ntified by ImageJ

Initial velocity me
easurementss of Sst2 Cyss397Ala weree determineed and Michaelis‐
Menten
M
parameters were
e used to de
etermine a k cat of 0.009 + 0.0004 s‐1 and a KM off 32.7
+ 4.6 μM forr the mutantt, with the assay
a
being repeated in
n triplicate aand averageed for
in
ncreased acccuracy of parrameters (Figure 4.18).

Figure 4.1
18 Sst2 C397
7A cleavage assay resultts, summarizzed by Michaaelis‐Menten
param
meters glean
ned from a triplicate
t
gell‐based K63‐‐DiUb cleavaage assay
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The Cyss397Ala muttant has a ve
ery similar K M value to aall of the other constructs in
th
his study, bu
ut has a dram
matic 166‐fo
old decreasee in kcat when
n compared to wild typee and
an 18‐19 fold
d decrease when
w
compaared to the alanine and
d tryptophan
n mutants (TTable
4.5). This ind
dicates that although th
he mutation was not do
one at the ccatalytic zincc, this
sttructural zinc residue co
ould be form
ming critical interactionss in the prottein that catalytic
activity is significantly diminished wh
hen removeed, supporteed by the diffferences in seen
n CD, thermaal melt, and TM values off the mutantt compared to wild typee (Figure 4.19
in
9).

Table 4.5 Sst2
S C397A kinetic
k
param
meters comppared to wild
d type, F403
3W, and F403A

In the
e previously mentioned Sato study,, the equivaalent of Sst2
2 C397 (AMSSH‐LP
w but a cysteine to seerine mutattion was cho
osen instead
d with
C402) was exxamined as well,
th
he same goal of destab
bilizing the structural zzinc.3 Their ggel based kkinetic assayy was
performed att a concentration of 1 µM AMSH‐LLP C402S, ggenerating a kcat of 0.00
02 s‐1.
o wild type AMSH‐LP,
A
this mutation caused a 4000 fold decreease in the vvalue
Compared to
he results se
een with thee C397A mutation in Sstt2. This dram
matic
of kcat, comparable to th
decrease in kcat seen in tw
wo differentt constructs at the samee site once aagain stressees the
im
mportance of
o the retention of the sttructural zincc to catalyticc activity.
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Figure 4.19 CD
C and thermal melt stu
udies of Sst22 C397A (A) C
CD of Sst2 C397A compaared
to wild typ
pe (B) Therm
mal melt of Sst2 C397A, sshowing a diifferent meltting curve an
nd
er TM than w
wild type
lowe

78
4.7

Future Directions of the Project

While the studies that have been completed paint a pretty clear picture
highlighting the importance of the 403 residue in Sst2 to dynamics and catalysis of the
construct, several other studies are in progress to help prove this theory further. First, a
simulated annealing experiment will be conducted in order to determine the lowest
energy state of both the tryptophan and alanine mutants compared to wild type Sst2 in
a simulated heating and subsequent cooling experiment. Additionally, ITC of a
catalytically inactive F403W mutant capable of binding diubiquitin (Sst2 F403W D354A
E286A) will be done and compared to that of previously published catalytically inactive
WT Sst2 (Sst2 E286A), giving us a better idea of the binding of the substrate (diubiquitin).
Finally, to thoroughly investigate all surrounding loop residues, the importance of
residue Asp315 will be examined by mutating the residue to alanine. Kinetic parameters
will be determined by gel based assay and compared to already determined values of
the other loop mutants to see how important this residue is to catalysis.
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APPENDIX
PRIMERS USED FOR CLONING AND MUTAGENESIS
5.1 Cloning primers for Sst2cat
Forward Sequence:
GCA GGA ACT TTT AAA ATT
245 246 247 248 249 250
Forward primer:
GCA TGC GGA TCC GCA GGA ACT TTT AAA
Nonsense BamH1 |‐‐‐‐‐‐‐Sst2 245‐249 ‐‐‐‐‐‐|
48% GC
Length: 27
TM = 60o
Reverse sequence:
GAT TTG AGG GTT AAA TAG
431 432 433 434 435 436
Reverse primer:
GCA TGC CTC GAG TTA TTT AAC CCT CAA
Nonsense Xho1 stop |‐‐Sst2 431‐435‐‐|
44% GC
Length: 27
TM = 58o
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5.2 Mutagenesis primers for Sst2 T316A

Template

311 312 313 314 315 316 317 318 319 320 321
GAA GCT ACT AGT GAC ACT TGT GGA ACA ACG GAT

Fwd

GAA GCT ACT AGT GAC GCT TGT GGA ACA ACG GAT
49% GC content, TM = 72o

Rev

ATC CGT TGT TCC ACA AGC GTC ACT AGT AGC TTC
49% GC content, TM = 72o

5.3 Mutagenesis primers for Sst2 F403W

Template

398 399 400 401 402 403 404 405 406 407 408
CGA AAA CCT GGG CTT TTT CAT CCA CAT GAG GGA

Fwd

CGA AAA CCT GGG CTT TGG CAT CCA CAT GAG GGA
55% GC content, TM = 80o

Rev

TCC CTC ATG TGG TTG AGC AAG CCC AGG TTT TCG
55% GC content, TM = 80o
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5.4 Mutagenesis primers for Sst2 F403W D354A E286A

#1) Sst2 F403W  Sst2 F403W D354A

Template

349 350 351 352 353 354 355 356 357 358 359
TTT ATG AGT AGC GTG GAT TTG CAT ACT CAT TGT

Fwd

TTT ATG AGT AGC GTG GCT TTG CAT ACT CAT TGT
40% GC content, TM = 70o

Rev

ACA ATG AGT ATG CAA AGC CAC GCT ACT CAT AAA
40% GC content, TM = 70o

#2) Sst2 F403W D354A  Sst2 F403W D354A E286A

Template

281 282 283 284 285 286 287 288 289 290 291
ACT AAA AAA AAT CTT GAA ACA TGT GGA ATT TTA

Fwd

ACT AAA AAA AAT CTT GCA ACA TGT GGA ATT TTA
24% GC content, TM = 65o

Rev

TAA AAT TCC ACA TGT TGC AAG ATT TTT TTT AGT
24% GC content, TM = 65o

5.5 Mutagenesis primers for AMSH‐LP F407W

Template

402 403 404 405 406 407 408 409 410 411 412
TGT AAA AAA AAG GCG TTC CAT CCA GAC ACC AAG

Fwd

TGT AAA AAA AAG GCG TGG CAT CCA GAC ACC AAG
46% GC content, TM = 75o

Rev

CTT GGT GTG TGG ATG CCA GCC CTT TTT TTT ACA
46% GC content, TM = 75o

